AIM ImmunoTech (AIM) has the following price history information. Looking back at AIM historical stock prices for the last five trading days, on October 08, 2024, AIM opened at $0.27, traded as high as $0.29 and as low as $0.26, and closed at $0.26. Trading volume was a total of 267.20K shares. On October 09, 2024, AIM opened at $0.26, traded as high as $0.27 and as low as $0.25, and closed at $0.26. Trading volume was a total of 144.60K shares. On October 10, 2024, AIM opened at $0.25, traded as high as $0.26 and as low as $0.25, and closed at $0.26. Trading volume was a total of 90.80K shares. On October 11, 2024, AIM opened at $0.26, traded as high as $0.28 and as low as $0.26, and closed at $0.27. Trading volume was a total of 70.70K shares. On October 14, 2024, AIM opened at $0.27, traded as high as $0.28 and as low as $0.25, and closed at $0.26. Trading volume was a total of 219.80K shares.

AIM Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AIM ImmunoTech shares, starting with a $10,000 purchase of AIM, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	10/16/2014
End date:	10/14/2024
Start price/share:	$0.32
End price/share:	$0.26
Dividends collected/share:	$0.00
Total return:	-18.75%
Average Annual Total Return:	-2.05%
Starting investment:	$10,000.00
Ending investment:	$8,128.67
Years:	10.00

AIM Historical Price Range
Date	Open	High	Low	Close	Volume
10/08/2024	$0.27	$0.29	$0.26	$0.26	267.20K
10/09/2024	$0.26	$0.27	$0.25	$0.26	144.60K
10/10/2024	$0.25	$0.26	$0.25	$0.26	90.80K
10/11/2024	$0.26	$0.28	$0.26	$0.27	70.70K
10/14/2024	$0.27	$0.28	$0.25	$0.26	219.80K

About AIM ImmunoTech

AIM ImmunoTech is an immuno-pharma company that is focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases and immune-deficiency disorders. Co.'s primary pharmaceutical product platform consists of Ampligen® and Alferon N Injection®. Ampligen is approved for sale in Argentina for severe Chronic Fatigue Syndrome (CFS) and is an experimental drug in the U.S. undergoing clinical development for the treatment of certain cancers and myalgic encephalomyelitis/CFS. Alferon N Injection is a natural alpha interferon for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.

AIM Historical Closing Prices
Date	Close
10/08/2024	$0.26
10/09/2024	$0.26
10/10/2024	$0.26
10/11/2024	$0.27
10/14/2024	$0.26

Healthcare Historical Prices

AIM is categorized under the Healthcare sector; below are some other companies in the same sector: AIMD Historical Stock Prices AIMT Historical Stock Prices AIPT Historical Stock Prices AIQ Historical Stock Prices AIRM Historical Stock Prices AIRS Historical Stock Prices AITB Historical Stock Prices AKAO Historical Stock Prices AKBA Historical Stock Prices AKCA Historical Stock Prices Free AIM Email Alerts: Get Dividend Alerts Get SEC Filing Alerts

AIM Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.